Mads Hansen

5.0k total citations · 1 hit paper
26 papers, 2.0k citations indexed

About

Mads Hansen is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mads Hansen has authored 26 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Mads Hansen's work include Lymphoma Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (10 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Mads Hansen is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (10 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Mads Hansen collaborates with scholars based in Denmark, Sweden and United States. Mads Hansen's co-authors include Annika Loft, Martin Hutchings, Lena Specht, Francesco d’Amore, Anne Kiil Berthelsen, A. M. Boesen, Susanne Keiding, Lars Møller Pedersen, Jesper Jurlander and Simon Buus and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Mads Hansen

24 papers receiving 2.0k citations

Hit Papers

Early Interim 2-[ 18 F]Fluoro-2-Deoxy-D-Glucose Positron ... 2007 2026 2013 2019 2007 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Early Interim 2-[ 18 F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study
    2007 552 citations Andrea Gallamini, Martin Hutchings et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mads Hansen Denmark 14 1.6k 712 614 586 553 26 2.0k
Ralph Naumann Germany 21 1.6k 1.0× 819 1.2× 588 1.0× 604 1.0× 986 1.8× 52 2.9k
M. André France 7 933 0.6× 196 0.3× 242 0.4× 332 0.6× 564 1.0× 10 1.3k
Barbara Kiesewetter Austria 21 1.1k 0.7× 256 0.4× 325 0.5× 346 0.6× 627 1.1× 102 1.6k
Paul Fields United Kingdom 21 1.2k 0.8× 368 0.5× 302 0.5× 386 0.7× 807 1.5× 58 2.5k
R S Cox United States 20 1.0k 0.7× 141 0.2× 747 1.2× 334 0.6× 712 1.3× 25 2.1k
A.R. Timothy United Kingdom 16 807 0.5× 621 0.9× 521 0.8× 348 0.6× 251 0.5× 29 1.4k
Mathias Hänel Germany 21 814 0.5× 153 0.2× 228 0.4× 355 0.6× 675 1.2× 72 1.8k
Maurizio Martelli Italy 20 1.2k 0.8× 124 0.2× 195 0.3× 477 0.8× 641 1.2× 101 1.6k
Hervé Ghesquières France 31 2.1k 1.4× 211 0.3× 274 0.4× 877 1.5× 1.6k 2.8× 193 3.0k
Ho‐Jin Shin South Korea 22 691 0.4× 233 0.3× 234 0.4× 222 0.4× 655 1.2× 182 2.0k

Countries citing papers authored by Mads Hansen

Since Specialization
Citations

This map shows the geographic impact of Mads Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mads Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mads Hansen more than expected).

Fields of papers citing papers by Mads Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mads Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mads Hansen. The network helps show where Mads Hansen may publish in the future.

Co-authorship network of co-authors of Mads Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Mads Hansen. A scholar is included among the top collaborators of Mads Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mads Hansen. Mads Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schöllkopf, Claudia, Mads Melbye, Lars Munksgaard, et al.. (2008). Borrelia infection and risk of non-Hodgkin lymphoma. Blood. 111(12). 5524–5529. 63 indexed citations
3.
Brown, Peter de Nully, Lars Møller Pedersen, Bjarne Bach Pedersen, et al.. (2008). Follicular lymphoma in young patients (>50 yrs): A population-based analysis of the Danish lymphoma registry. Annals of Oncology. 19. 176–176. 4 indexed citations
4.
d’Amore, Francesco, Peter de Nully Brown, Lars Møller Pedersen, et al.. (2008). Primary refractory disease in non-Hodgkin lymphoma (NHL): Occurence, clinico-pathological features, and outcome. Annals of Oncology. 19. 132–132. 1 indexed citations
5.
Schöllkopf, Claudia, Karin E. Smedby, Henrik Hjalgrim, et al.. (2008). Hepatitis C infection and risk of malignant lymphoma. International Journal of Cancer. 122(8). 1885–1890. 61 indexed citations
6.
7.
Gallamini, Andrea, Martin Hutchings, Luigi Rigacci, et al.. (2007). Early Interim 2-[ 18 F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study. Journal of Clinical Oncology. 25(24). 3746–3752. 552 indexed citations breakdown →
8.
Sjø, Lene Dissing, Christian Bjørn Poulsen, Mads Hansen, Michael Møller, & Elisabeth Ralfkiær. (2007). Profiling of diffuse large B‐cell lymphoma by immunohistochemistry: identification of prognostic subgroups. European Journal Of Haematology. 79(6). 501–507. 42 indexed citations
9.
Hutchings, Martin, Annika Loft, Mads Hansen, Elisabeth Ralfkiær, & Lena Specht. (2006). Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake. Hematological Oncology. 24(3). 146–150. 63 indexed citations
10.
Hutchings, Martin, Annika Loft, Mads Hansen, Anne Kiil Berthelsen, & Lena Specht. (2006). Clinical impact of FDG‐PET/CT in the planning of radiotherapy for early‐stage Hodgkin lymphoma. European Journal Of Haematology. 78(3). 206–212. 73 indexed citations
11.
Tholstrup, Dorte, Mads Hansen, Peter de Nully Brown, & Jesper Jurlander. (2006). Acquired Immunodeficiency and Malnutrition in Patients Treated with Bi-Weekly CHOP-Based Chemotherapy for Diffuse Large B-Cell Lymphoma.. Blood. 108(11). 2443–2443. 1 indexed citations
12.
Brown, Peter de Nully, Jesper Jurlander, Ola Lindén, & Mads Hansen. (2005). Radioimmunoterapi ved non-Hodgkins lymfom. Ugeskrift for Læger. 167(41). 9–3867. 1 indexed citations
13.
Smedby, Karin E., Henrik Hjalgrim, Mads Melbye, et al.. (2005). Ultraviolet Radiation Exposure and Risk of Malignant Lymphomas. JNCI Journal of the National Cancer Institute. 97(3). 199–209. 178 indexed citations
14.
d’Amore, Francesco, Thomas Relander, Hans Hagberg, et al.. (2005). HuMax-CD4 (Zanolimumab), a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in CD4+ Peripheral T-Cell Lymphoma of Non-Cutaneous Type.. Blood. 106(11). 3354–3354. 5 indexed citations
15.
Hansen, Mads, et al.. (2000). The lady who had muscle cramps and developed thrombotic microangiopathy. Nephrology Dialysis Transplantation. 15(9). 1464–1467. 5 indexed citations
16.
Nexø, Ebba, Mads Hansen, Karsten Boye Rasmussen, Anders Lindgren, & Ralph Gräsbeck. (1994). How to diagnose cobalamin deficiency. Scandinavian Journal of Clinical and Laboratory Investigation. 54(sup219). 61–76. 68 indexed citations
17.
Hansen, Mads, Peter Gimsing, Steen Ingeberg, H Jans, & Ebba Nexø. (1992). Cobalamin binding proteins in patients with HIV infection. European Journal Of Haematology. 48(4). 228–231. 7 indexed citations
18.
Rose, Carsten, J. A. Andersen, Knud Andersen, et al.. (1991). [Adjuvant endocrine treatment of postmenopausal patients with breast cancer with high risk of recurrence. 5. Results from the DBCG (Danish Breast Cancer Cooperative Group) 77C randomized trial].. PubMed. 153(33). 2283–7. 1 indexed citations
19.
Hansen, Mads & Marijke Fràter‐Schröder. (1987). Human transcobalamin isopeptides: Separation by isoelectric focusing and by polyacrylamide gel electrophoresis. Electrophoresis. 8(5). 221–223. 14 indexed citations
20.
Panduro, J., Mads Hansen, & H.H. Hansen. (1982). Oral VP-16-213 in Transitional Cell Carcinoma of the Bladder: A Phase II Study. The Journal of Urology. 127(1). 191–191. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralph Naumann Breakdown of academic impact, for papers by M. André Breakdown of academic impact, for papers by Barbara Kiesewetter Breakdown of academic impact, for papers by Paul Fields Breakdown of academic impact, for papers by R S Cox Breakdown of academic impact, for papers by A.R. Timothy Breakdown of academic impact, for papers by Mathias Hänel Breakdown of academic impact, for papers by Maurizio Martelli Breakdown of academic impact, for papers by Hervé Ghesquières Breakdown of academic impact, for papers by Ho‐Jin Shin
Rankless by CCL
2026